Form 4: Ocular Therapeutix Executive Sells Shares
Insider Transaction (Form 4)
Jeffrey S. Heier, Chief Scientific Officer of Ocular Therapeutix, Inc, sold 3,296 shares of common stock on August 24, 2026 for $10.78 per share.
Summary
- Open-market sale: disposed of 3,296 Common Stock at $10.78 ($35,531) on August 24, 2026; holds 318,326 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $35,531 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Jeffrey S. Heier — Officer (Chief Scientific Officer)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-08-24 | Open-market sale | Common Stock | 3,296 | $11 | $35.5K | 318,326 |
Key Dates
| Date | Description |
|---|---|
| 2026-08-24 | Open-market sale (3,296 shares) |
Keywords
insider transaction, Form 4, OCUL, OCULAR THERAPEUTIX, INC, bearish, Jeffrey S. Heier
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.